Major shareholder announcement

In accordance with section 29 of the Danish Securities Trading Act, Novozymes hereby announces that it has been informed that Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, now holds 5.04% of the B shares in Novozymes, previously reported at 4.99% in company announcement no. 14, March 2016.

 | Source: Novonesis (Novozymes A/S) Novonesis (Novozymes A/S)

Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, now holds B shares in Novozymes A/S to a total of 15,639,344 shares of a nominal value of DKK 31,278,688, equivalent to 5.04% of Novozymes A/S’ share capital and 1.97% of the voting rights.

Attachments

2016_16_Major Shareholder Announcement_EN.pdf

Recommended Reading